Legal status · Canada
Is PEG-loxenatide legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. PEG-loxenatide is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
PEG-loxenatide in Canada at a glance
| Classification | Not approved |
|---|---|
| Note | No Health Canada submission located. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 4 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the PEG-loxenatide profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing PEG-loxenatide is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What PEG-loxenatide is
Approved in China in 2019 on two placebo-controlled phase 3 trials in 361 and about 360 patients, where it lowered glycated haemoglobin about 1.0 to 1.3 percentage points. Its weight effect in those registration trials was small; the large weight figures come from later single-centre trials at doses well above the licensed ones.
Polyethylene glycol loxenatide, usually written PEX168 in the trial literature, is a PEGylated analogue of exendin-4 from Hansoh Pharmaceutical. It was approved in China in 2019, which makes it one of the earliest domestically developed weekly GLP-1 agonists to reach a market anywhere.
Mechanism: An analogue of exendin-4 modified with polyethylene glycol at a defined site. PEGylation increases molecular size and slows renal clearance, converting a peptide that would need twice-daily injection into a once-weekly one.
Regulatory history: Not approved in the United States. Approved in China in 2019 for type 2 diabetes and widely used there. No Western regulatory filing located.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for PEG-loxenatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
PEG-loxenatide in other countries
Frequently asked questions
Is PEG-loxenatide legal in Canada?
No. PEG-loxenatide is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: No Health Canada submission located.
Can I buy PEG-loxenatide in Canada?
No approved product exists to buy. In Canada PEG-loxenatide is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No Health Canada submission located.
Is PEG-loxenatide Health Canada approved?
No. In Canada PEG-loxenatide is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved in the United States. Approved in China in 2019 for type 2 diabetes and widely used there. No Western regulatory filing located.. On the evidence, 4 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for PEG-loxenatide live on its compound profile.
PEG-loxenatide profileThis page is general information about the regulatory status of PEG-loxenatide in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.